Literature DB >> 19655218

Mechanism of phosphate-induced calcification in rat aortic tissue culture: possible involvement of Pit-1 and apoptosis.

Sachiko Mune1, Maki Shibata, Ikuji Hatamura, Fumie Saji, Tadashi Okada, Yuka Maeda, Toshifumi Sakaguchi, Shigeo Negi, Takashi Shigematsu.   

Abstract

BACKGROUND: Hyperphosphataemia is a known contributing factor in the progression of vascular calcification in dialysis patients. The cellular mechanisms underlying phosphate-induced calcification are still unclear despite intense study, so in this study, we investigated the possible involvement of the type III sodium-dependent phosphate cotransporter, Pit-1, in an aortic tissue culture model.
METHODS: Aortic segments from 9-week-old male Sprague-Dawley rats were incubated in serum-supplemented medium for 10 days. The phosphate concentration of the medium was elevated to induce calcification, which was assessed by histology and calcium content. Phosphonoformic acid (PFA) was used to inhibit phosphate uptake. The involvement of apoptosis was examined using the terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate (dUTP) nick-end labelling (TUNEL) assay, caspase 3 activation, and inhibition of apoptosis using a general caspase inhibitor. Phenotypic changes in vascular smooth muscle cells (VSMC) were assessed using expression of osteochondrogenic differentiation markers.
RESULTS: Medial vascular calcification was induced in aortas cultured in a high phosphate medium. PFA decreased the rates of calcification and apoptosis of VSMC in the media, concomitant with calcification. Caspase inhibitor reduced calcification. No phenotypic transition of VSMC was seen in this model.
CONCLUSIONS: These results indicate that phosphate uptake through the type III sodium-dependent phosphate cotransporter, Pit-1, leads to induction of apoptosis and subsequent calcification of VSMC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655218     DOI: 10.1007/s10157-009-0208-0

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  20 in total

1.  Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.

Authors:  J Blacher; A P Guerin; B Pannier; S J Marchais; G M London
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

2.  Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells.

Authors:  Neal X Chen; Kalisha D O'Neill; Danxia Duan; Sharon M Moe
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

3.  Phosphate regulation of vascular smooth muscle cell calcification.

Authors:  S Jono; M D McKee; C E Murry; A Shioi; Y Nishizawa; K Mori; H Morii; C M Giachelli
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

4.  Inorganic phosphate induces apoptosis of osteoblast-like cells in culture.

Authors:  Z Meleti; I M Shapiro; C S Adams
Journal:  Bone       Date:  2000-09       Impact factor: 4.398

5.  Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis.

Authors:  Michael Schoppet; Nadia Al-Fakhri; Folker E Franke; Norbert Katz; Peter J Barth; Bernhard Maisch; Klaus T Preissner; Lorenz C Hofbauer
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

6.  Chemical and hormonal determinants of vascular calcification in vitro.

Authors:  K Lomashvili; P Garg; W C O'Neill
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

7.  Pivotal role of Bcl-2 family proteins in the regulation of chondrocyte apoptosis.

Authors:  Yasushi Oshima; Toru Akiyama; Atsuhiko Hikita; Mitsuyasu Iwasawa; Yuichi Nagase; Masaki Nakamura; Hidetoshi Wakeyama; Naohiro Kawamura; Toshiyuki Ikeda; Ung-il Chung; Lothar Hennighausen; Hiroshi Kawaguchi; Kozo Nakamura; Sakae Tanaka
Journal:  J Biol Chem       Date:  2008-07-16       Impact factor: 5.157

8.  Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway.

Authors:  Bo-Kyung Son; Koichi Kozaki; Katsuya Iijima; Masato Eto; Taro Kojima; Hidetaka Ota; Yuka Senda; Koji Maemura; Toru Nakano; Masahiro Akishita; Yasuyoshi Ouchi
Journal:  Circ Res       Date:  2006-03-23       Impact factor: 17.367

9.  The elastic lamellae of devitalized arteries calcify when incubated in serum: evidence for a serum calcification factor.

Authors:  Paul A Price; Wai Si Chan; Dawn M Jolson; Matthew K Williamson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-09       Impact factor: 8.311

10.  Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification.

Authors:  Xianwu Li; Hsueh-Ying Yang; Cecilia M Giachelli
Journal:  Circ Res       Date:  2006-03-09       Impact factor: 17.367

View more
  15 in total

1.  Magnesium prevents phosphate-induced vascular calcification via TRPM7 and Pit-1 in an aortic tissue culture model.

Authors:  Tomohiro Sonou; Masaki Ohya; Mitsuru Yashiro; Asuka Masumoto; Yuri Nakashima; Teppei Ito; Toru Mima; Shigeo Negi; Hiromi Kimura-Suda; Takashi Shigematsu
Journal:  Hypertens Res       Date:  2017-01-26       Impact factor: 3.872

2.  Vascular smooth muscle cell differentiation to an osteogenic phenotype involves matrix metalloproteinase-2 modulation by homocysteine.

Authors:  Tingjiao Liu; Jinghan Lin; Ting Ju; Lei Chu; Liming Zhang
Journal:  Mol Cell Biochem       Date:  2015-05-19       Impact factor: 3.396

3.  Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia.

Authors:  Domenick A Prosdocimo; Steven C Wyler; Andrea M Romani; W Charles O'Neill; George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-16       Impact factor: 4.249

Review 4.  Chronic Kidney Disease-Mineral and Bone Disorders: Pathogenesis and Management.

Authors:  Jorge B Cannata-Andía; Beatriz Martín-Carro; Julia Martín-Vírgala; Javier Rodríguez-Carrio; José Joaquín Bande-Fernández; Cristina Alonso-Montes; Natalia Carrillo-López
Journal:  Calcif Tissue Int       Date:  2020-11-15       Impact factor: 4.333

5.  Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.

Authors:  Barbara Bruna Abreu de Castro; Wander Barros do Carmo; Paulo Giovani de Albuquerque Suassuna; Moises Carminatti; Julia Bianchi Brito; Wagner Vasques Dominguez; Ivone Braga de Oliveira; Vanda Jorgetti; Melani Ribeiro Custodio; Helady Sanders-Pinheiro
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

Review 6.  Phosphate: an old bone molecule but new cardiovascular risk factor.

Authors:  Navid Shobeiri; Michael A Adams; Rachel M Holden
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

7.  Endothelin but Not Angiotensin II May Mediate Hypertension-Induced Coronary Vascular Calcification in Chronic Kidney Disease.

Authors:  Simon W Rabkin
Journal:  Int J Nephrol       Date:  2011-05-31

8.  Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner.

Authors:  Fatih Kircelli; Mirjam E Peter; Ebru Sevinc Ok; Fatma Gul Celenk; Mumtaz Yilmaz; Sonja Steppan; Gulay Asci; Ercan Ok; Jutta Passlick-Deetjen
Journal:  Nephrol Dial Transplant       Date:  2011-07-12       Impact factor: 5.992

9.  Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223.

Authors:  Ashraf Yusuf Rangrez; Eléonore M'Baya-Moutoula; Valérie Metzinger-Le Meuth; Lucie Hénaut; Mohamed Seif el Islam Djelouat; Joyce Benchitrit; Ziad A Massy; Laurent Metzinger
Journal:  PLoS One       Date:  2012-10-18       Impact factor: 3.240

10.  High expression of the Pi-transporter SLC20A1/Pit1 in calcific aortic valve disease promotes mineralization through regulation of Akt-1.

Authors:  Diala El Husseini; Marie-Chloé Boulanger; Dominique Fournier; Ablajan Mahmut; Yohan Bossé; Philippe Pibarot; Patrick Mathieu
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.